Results for tag: "Pulmonary Drug"

The Pulmonary Drug market is a subset of the larger Respiratory Drug market, which includes treatments for a variety of respiratory diseases and conditions. Pulmonary Drugs are used to treat diseases and conditions of the lungs, such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pulmonary hypertension. These drugs are typically inhaled, and can include bronchodilators, corticosteroids, and antibiotics. In addition, Pulmonary Drugs can also be used to treat other respiratory conditions, such as sleep apnea and snoring. The Pulmonary Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Pfizer, and AstraZeneca. Other companies, such as Boehringer Ingelheim, Cipla, and Sun Pharmaceuticals, also offer Pulmonary Drugs. Show Less Read more